Celmatix is a next-generation women’s health company leveraging big-data and genomics. Founded by Laura Towart Bandak and Piraye Yurttas Beim in 2009, Celmatix is backed by investors that include Brainchild Holdings, GLG (Gerson Lehrman Group), Richmond Global Ventures, and Topspin Partners and is headquartered in New York.